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Near infrared spectroscopic assessment of lipid core plaque changes after
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Background: Intravascular near-infrared spectroscopy (NIRS) has been validated for
assessment of confluent lipid core plaque (LCP) while virtual histology intravascular
ultrasound (VH-IVUS) classifies plaque as necrotic core (NC), fibrofatty, fibrotic, or
dense calcium.
Methods: We performed both NIRS and VH-IVUS pre- and post-intervention in a
cohort of 30 pts to evaluate LCP changes after coronary artery stenting. Based on the
NIRS block chemogram(a metric of the probability of LCP in a 2mm-long NIRS
chemogram segment),we excluded 5 lesions without any LCP (no yellow blocks,the
highest probability of LCP). We divided the other 25 pts into 2 groups: A – lesions
with a ≥2 block reduction in the number of yellow or tan blocks (2 highest probabilities
of LCP, n=17) in the post-stent block chemogram and B – lesions with little or no
change post-stenting (n=8).VH-IVUS assessment of the worst 10mm-long lumen-
compromised segment included quantitative measures of the 4 plaque components and
the presence of a VH thin cap or thick-cap fibroatheroma(TCFA or ThCFA)
Results: 51% of pts presented with acute coronary syndrome. The average stent size
(2.9±0.3mm) and total stent length (22.3±6.6mm) were comparable between the 2
groups. Pre-intervention lipid core burden index (LCBI) was similar in both groups,
but was significantly reduced post-stenting in Group A.Pre-intervention VH-IVUS
showed that Group A had a smaller minimum lumen area(MLA) with a greater plaque
burden at the MLA site, and a trend toward longer VH-TCFA, but shorter ThCFA
(Table).
Conclusion: more than half (56.6%) of lesions have a decrease in LCP (NIRS) after
coronary stent implantation. The presence of a longer superficial NC (VH-TCFA)
predicted the plaques that would have a reduced lipid core after stenting
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Acute effects of nicardipine and esmolol on the cardiac cycle, hemodynamic and
endothelial shear stress in patients with unstable angina pectoris and moderate
coronary stenosis: results from single center, randomized study
Shao-Liang Chen, Zuo-Ying Hu, Jun-Jie Zhang, Fei Ye
Nanjing First Hospital, Nanjing Medical University, Nanjing, China
Background: Nicardipine and esmolol exhibit cardioprotection via different
mechanisms. However, their acute effects on hemodynamic and ESS are still unknown.
Methods: 116 patients with unstable angina and moderate coronary stenosis were
randomly divided into nicardipine (n=59) and esmolol (n=57) groups. Both drugs were
injected as a bolus followed by continuous infusion to achieve the steady states defined
as the mean blood pressure (MBP) reduced by ≥10% or a heart-rate change by ≥15
bpm, lasting for at least 10 min. The aortic pressure (AP), EKG, blood velocity, right
atrial pressure, distal coronary pressure (DCP), systolic time (ST), isovolumetric
diastolic time (IVDT), speed filling time (SFT) and endothelial shear stress (ESS) were
simultaneously calculated at baseline and steady states.
Results: Both drugs significantly reduced blood pressure and rate-pressure load.
Nicardipine was associated with negative remodeling of the distal segment. Esmolol
increased minimal lumen diameter (p=0.040), prolonged SFT (0.34±0.03 s vs.
0.41±0.03 s, p<0.001), reduced DCP (p<0.001) and increased blood velocity
(33.65±1.07 cm/s vs. 43.36±1.25 cm/s, p<0.001) at SFT stages, with increased blood-
flow (p<0.001). Both drugs increased downstream ESS. Esmolol significantly reversed
abnormally increased ESS (p<0.001) and increased upstream ESS compared with
nicardipine (p<0.001).
Conclusion: Beyond a similar reduction of AP, patients with UA and MCS could
benefit more from the reduction of heart rate induced by esmolol, rather than
nicardipine (ChiCTR-TRC-10000964).
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New Insights Into The Coronary Artery Bifurcation: Hypothesis Generating
Concepts Utilising 3-Dimensional Optical Frequency Domain Imaging
Vasim Farooq, Patrick W Serruys, Jung Ho Heo, Bill D Gogas, Takayuki Okamura,
Yoshinobu Onuma, Josep Gomez-Lara, Salvatore Brugaletta, Maria Radu, Roberto
Diletti, Hector M Garcìa-Garcìa, Robert Jan van Geuns
Interventional Cardiology, ThoraxCenter, ERASMUS MC, Rotterdam, Netherlands
Background: Coronary artery bifurcations are a common challenging lesion subset
approximating to 10-20% of all PCI. Provisional T-stenting (Prov-T) is generally
recommended as the first line management of most lesions. Carina shift is the
predominant mechanism of side-branch (SideB) pinching during Prov-T & has been
indirectly inferred from benchwork & 2D intravascular imaging modalities.
Methods: Offline 3D reconstructions of coronary bifurcations & the effects of Prov-
T from patients in the FIM trial of the high-frequency (160 fr/s) Terumo OFDI system
were undertaken. 3D QCA were performed to assess the bifurcation angulation.
Results: Through a series of 3D reconstructions several novel hypothesis-generating
concepts are presented. The principles of “perpendicular” & “parallel” bifurcations &
the clinical implications for SideB closure are demonstrated. It is postulated that the
appearances of the carina secondary to the angle of divergence between the main-
branch (MainB) & SideB origins dictates how the SideB will react to the effects of
MainB stenting. A more perpendicular take-off of the SideB from the MainB may not
be affected by carina shift, whereas a shallower angle of divergence between MainB
& SideB origins may potentially expose the SideB to risk of closure. The principle of
re-crossing of the coronary wire (after MainB stenting) into the SideB through the most
distal cell of the MainB stent covering the SideB opening, & implications of resultant
malapposed struts with metallic extension of the carina if not undertaken are
demonstrated.
LAD-DIAGONAL parallel bifurcation. Downstream fly-through, (1) aimed at D1
(2) & perpendicular (3) views are illustrated
Conclusion: The potential for the clinical application of 3D frequency domain OCT
as a complimentary tool to 2D imaging is demonstrated. A reassessment of the
understanding of 2D OCT imaging may be warranted in light of the 3D findings. Real-
time, instantaneous, high resolution 3D OCT with quantitative properties are required
from industry to validate & apply this technology in conventional PCI practice. This
may aid in the further understanding of the complexities of the coronary bifurcation.
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Long-Term Follow-Up of a Large Cohort of Patients with Intermediate Lesions
Assessed with IVUS
Jose M De la Torre Hernandez, Tamara Garcia Camarero, Gonzalo Martin Gorria,
Blanca Arnaez, Piedad Lerena, Dae-Hyun Lee, Fermin Sainz Laso, Javier Zueco
Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain
Background: The assessment of intermediate lesions can be done with IVUS.
However the indication of revascularization based on this strategy and the safety of
this approach has been evaluated in small studies without really long-term follow up.
Methods: We have analyzed the clinical outcome of all consecutive pts with
intermediate lesions (40-60% stenosis) who underwent IVUS examination in a 4 years
period (2004-2007) in our institution. The criteria for revascularization was a minimum
lumen area < 4mm2 in vessels >3 mm and < 3.5 mm2 in vessels 2.5-3 mm.
Results: A total of 340 pts were included (408 lesiones studied). After IVUS
examination 225 (55%) lesions were left untreated in 185 pts. In this group at 3 years
follow up there were 7 deaths (3 cardiac and not lesion related) and 3 infarctions not
related with the target lesion. Regarding revascularizations, at 3 years 8 lesions (3.5%)
initially evaluated with IVUS in 8 pts (4.3%) required treatment due to progression.
In the first year of follow up the incidence of revascularization over target-lesions was
1%. In this follow up 5 pts (2.7%) underwent revascularization of new lesions and 11
pts (6%) over restenotic lesions.
Conclusion: The assessment of intermediate lesions with IVUS indicates
revascularization in almost half of lesions. At 3 years follow up the deferred group
shows a very low rate of lesion-related events, only revascularization of a 3.5% of
lesions.
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